Financial LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes Shared by Ken Dropiewski on March 4, 2024 More in Financial: AMT Medical Secures $25 Million in Series B Funding to Revolutionize Coronary Artery Bypass Surgery April 17, 2025 Instylla Announces the Appointment of Daniel Davis to Board of Directors April 15, 2025 Windtree Therapeutics Reports Year-End 2024 Financial Results and Provides Key Business Updates April 15, 2025 This post was originally published on this site Share this story Facebook Twitter LinkedIn LONDON–(BUSINESS WIRE)– #cardiacsurgery–LivaNova PLC announced its intention to offer $300 million aggregate principal amount of convertible senior notes due 2029 in a private offering.